Morepen Laboratories Limited has reported Consolidated financial results for the period ended March 31, 2022.
Financial Results (Q4 FY2022) - QoQ Comparison
The company has reported total income of Rs. 371.4634 crores during the period ended March 31, 2022 as compared to Rs. 399.1902 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs. 12.3224 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 21.5212 crores for the period ended December 31, 2021.
The company has reported EPS of Rs. 0.24 for the period ended March 31, 2022 as compared to Rs. 0.41 for the period ended December 31, 2021.
Total Income | ₹371.4634 crs | ₹399.1902 crs | -6.95% |
Net Profit | ₹12.3224 crs | ₹21.5212 crs | -42.74% |
EPS | ₹0.24 | ₹0.41 | -41.46% |
Financial Results (Q4 FY2022) - YoY Comparison The company has reported total income of Rs.371.4634 crores during the period ended March 31, 2022 as compared to Rs.290.7623 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.12.3224 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.26.7605 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.0.24 for the period ended March 31, 2022 as compared to Rs.0.59 for the period ended March 31, 2021.
Total Income | ₹371.4634 crs | ₹290.7623 crs | 27.76% |
Net Profit | ₹12.3224 crs | ₹26.7605 crs | -53.95% |
EPS | ₹0.24 | ₹0.59 | -59.32% |
Financial Results (Year Ended FY2022) - YoY Comparison The company has reported total income of Rs.1557.1341 crores during the Financial Year ended March 31, 2022 as compared to Rs.1200.1253 crores during the Financial Year ended March 31, 2021.
The company has posted net profit / (loss) of Rs.101.6813 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.97.09 crores for the Financial Year ended March 31, 2021.
The company has reported EPS of Rs.1.96 for the Financial Year ended March 31, 2022 as compared to Rs.2.15 for the Financial Year ended March 31, 2021.
Total Income | ₹1557.1341 crs | ₹1200.1253 crs | 29.75% |
Net Profit | ₹101.6813 crs | ₹97.09 crs | 4.73% |
EPS | ₹1.96 | ₹2.15 | -8.84% |
Shares of Morepen Laboratories Limited was last trading in BSE at Rs. 47.90 as compared to the previous close of Rs. 47.40. The total number of shares traded during the day was 660406 in over 6183 trades.
The stock hit an intraday high of Rs. 49.95 and intraday low of 47.20. The net turnover during the day was Rs. 31994843.00.
Source : Equity Bulls
Keywords
MorepenLaboratories
Q4FY22
FY2022
ResultUpdate